NMPA Approval

Brivudine Tablets

Approval Number

国药准字HJ20140208

Registration Date

June 17, 2024

Previous Approval Numbers

H20140208

Drug Information

Generic Name

溴夫定片

Trade Name

左代

Dosage Form

片剂

Strength

125mg

Drug Type

化学药品

Registration Date

June 17, 2024

Expiry Date

June 16, 2029

Company Address

Glienicker Weg 125, 12489 Berlin, Federal Republic of Germany

Company Address

Tempelhofer Weg 83,12347 Berlin, Federal Republic of Germany

Empowering clinical research with data-driven insights and AI-powered tools.

溴夫定片 - NMPA 批准文号 | MedPath